Table 3.
Clinical and safety outcome.
| TAVI – 30 day outcome | N = 56 |
| Death | |
| Death from any cause | 1 (1.78%) |
| Death from cardiovascular cause | 0 |
| Re-hospitalization | 3 (5.35%) |
| Death from any cause or re-hospitalization | 4 (7.1%) |
| Major bleeding | 4 (7.1%) |
| Stroke or TIA | |
| All | 0 |
| Stroke | 0 |
| Minor | 0 |
| Major | 0 |
| TIA | 0 |
| Death from any cause or Stroke | 1 (1.78%) |
| Myocardial infarction | 0 |
| Vascular complication | |
| All | 5 (8.92%) |
| Major | 4 (7.14%) |
| Acute Kidney Injury | 1 (1.78%) |
| Major bleeding | 4 (7.1%) |
| Cardiac re-interventions | |
| BAV | 0 |
| Re-TAVI | 0 |
| SAVR | 0 |
| Endocarditis | 0 |
| New atrial fibrillation | 0 |
| New pacemaker | 1 (1.78%) |